Insight on What Matters - So You Can Transform Your Business.
But successful biopharma partnerships don't happen by chance and negotiating an out-licensing deal can be complex—especially when the company may also be progressing the clinical portfolio.
The evaluation and approval process in commercial lending involves comprehensive information gathering and financial analysis in order to make a sound judgment regarding the borrower’s financial stability and ability to repay the loan.
Mission Capital chose ShareVaultTM from Pandesa, a leading provider of next generation virtual data rooms, to securely share sensitive or confidential due diligence documents that would enable them to grow and maintain a competitive edge in the rapidly expanding, fast paced real estate loan portfolio sales market.
The ability to modify the nucleotide sequence of a genome with precision is a critical aspect of genome editing.
When conducting due diligence on a target company, your goal is to thoroughly evaluate its affairs in order to make an informed decision as to whether to proceed with an acquisition.
Recent cutting-edge advances in genetic therapies are likely to provide game-changing treatments, if not cures, for many patients with rare inherited disorders.
The Leahy-Smith American Invents Act (AIA) is a United States federal statute that was passed by Congress and signed into law by President Barack Obama on September 16, 2011 establishing new trial proceedings to be conducted by the Patent Trial and Appeal Board (PTAB) in the United States Patent Office.x
Although today’s biotech industry venture funding levels are among the strongest in the sector’s history, some things haven't changed—the volatility resulting from constant innovation, uncertain outcome of clinical trials, and a changing regulatory environment, continue to create challenges both for facilitating growth and establishing strategic alliances.
Here are our top six best practices for streamlining the due diligence process and maximizing the value of your deal.